Vigil Neuroscience

Acquired

R&D-Driven and AI-Powered Biopharma Company | Sanofi

Cambridge, United States · Founded 2020 · $140.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$140.0M
Last Round
$90.0M Series BAug 2021
Rounds
2
Acquired by
SanofiAug 2025

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

Vigil Neuroscience was a biotechnology company founded in 2020 and headquartered in Cambridge, Massachusetts, focused on harnessing the power of microglia to develop treatments for neurodegenerative diseases. The company pipeline centered on TREM2 (Triggering Receptor Expressed on Myeloid cells 2), a key receptor that regulates microglial function in the brain, with both antibody and small molecule agonist programs targeting neuroinflammation in Alzheimer disease, rare leukodystrophies, and other CNS conditions. Vigil lead programs included VGL101, an anti-TREM2 antibody for CSF1R-related leukodystrophy, and VG-3927, a novel oral small molecule TREM2 agonist. The company raised $140 million in financing before being acquired by Sanofi in 2025 for $470 million, adding its investigational TREM2 agonist to Sanofi neurology pipeline.

Summary

Vigil Neuroscience is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $140.0M in total across 2 rounds, most recently a $90.0M Series B round in Aug 2021. Investors include Atlas Venture, Sanofi Ventures and Vida Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionAcquisition by SanofiAug 2025

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vigil Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/vigil-neuroscience"><img src="https://indexed.vc/api/badge/company/vigil-neuroscience" alt="Vigil Neuroscience on Indexed.vc" width="260" height="76" /></a>